124 related articles for article (PubMed ID: 38894565)
1. Efficacy and safety of fire needle therapy in treating non-segmental stable vitiligo: A randomized self-controlled clinical trial.
Wang Y; Lin M; Huang F; Jia R; Xu W; He Q; Xiong Q; Hu Q; Diao Q; Liu Z
J Cosmet Dermatol; 2024 Jun; ():. PubMed ID: 38894565
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental vitiligo: a randomized, controlled trial.
Saleh R; Ahmed AA; M Abd-Elmagid W
J Cosmet Dermatol; 2021 Dec; 20(12):3943-3952. PubMed ID: 33657259
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial.
Alshiyab D; Ba-Shammakh SA; Al-Fakih A; Tashman O; Sarakbi D; Al-Qarqaz F; Muhaidat J; Atwan A; Cork MJ
J Dermatolog Treat; 2024 Dec; 35(1):2296851. PubMed ID: 38124534
[TBL] [Abstract][Full Text] [Related]
4. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of 308-nm excimer laser as monotherapy and combination therapy with topical tacrolimus in the treatment of periocular vitiligo.
Zhou F; Chen S; Jin W; Lu Y; Gao Y; Wu J
Dermatol Ther; 2022 Jul; 35(7):e15556. PubMed ID: 35514034
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
[TBL] [Abstract][Full Text] [Related]
8. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
Majid I
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo.
Shah B; Godse K; Mahajan S; Grandhi S; Shendkar S; Sharma A; Teli C; Pathak R; Parsad D
Dermatol Ther; 2019 Nov; 32(6):e13109. PubMed ID: 31600833
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
Sisti A; Sisti G; Oranges CM
An Bras Dermatol; 2016 Apr; 91(2):187-95. PubMed ID: 27192518
[TBL] [Abstract][Full Text] [Related]
11. Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream.
Kathuria S; Khaitan BK; Ramam M; Sharma VK
Indian J Dermatol Venereol Leprol; 2012; 78(1):68-73. PubMed ID: 22199063
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.
Lo YH; Cheng GS; Huang CC; Chang WY; Wu CS
J Dermatol; 2010 Feb; 37(2):125-9. PubMed ID: 20175845
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
Dayal S; Sahu P; Gupta N
Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study.
Shah S; Sakhiya J; Deshpande P; Sakhiya D; Inamadar AC
J Clin Aesthet Dermatol; 2020 Feb; 13(2):E69-E75. PubMed ID: 32308788
[No Abstract] [Full Text] [Related]
15. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
Hu W; Xu Y; Ma Y; Lei J; Lin F; Xu AE
Clin Drug Investig; 2019 Dec; 39(12):1233-1238. PubMed ID: 31522334
[TBL] [Abstract][Full Text] [Related]
16. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
17. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
Abd-Elazim NE; Yassa HA; Mahran AM
J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
[TBL] [Abstract][Full Text] [Related]
18. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
Hartmann A; Bröcker EB; Hamm H
Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
[TBL] [Abstract][Full Text] [Related]
19. A randomized, prospective pilot study for comparison of a triple combination of 2940 nm Er:YAG Laser and triamcinolone acetonide solution with either 308 nm excimer laser or 0.1% tacrolimus in treatment of stable segmental vitiligo.
He M; Bao N; Qi RQ; Wu Y; Liu M
Dermatol Ther; 2022 Nov; 35(11):e15875. PubMed ID: 36181292
[TBL] [Abstract][Full Text] [Related]
20. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
